CLINICAL_TRIALS
research
· 2026-01-23
Clinical Trial Update: A Study of SHJ002 Sterile Ophthalmic Solution for Myopia Control [Phase 2]
Summary
Phase 2 study evaluating SHJ002 Sterile Ophthalmic Solution for progressive myopia is currently active but not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sunhawk Vision Biotech, Inc. | Conditions: Myopia, Progressive | Phase 2 | Status: ACTIVE_NOT_RECRUITING